EU’s Largest Private Biotech talking on the Future of mRNA Therapies

Today is the 3rd International mRNA Health Conference in Berlin. I jumped in the metro to go there and interview the most successful people of the field…

biontech-rna_webWe first interviewed Sean Marett, COO of BioNTech. This German Biotech is the largest private Biotech in EU and so far counts over 400 employees…BioNTech also  recently signed a huge €1.37 billion deal with Sanofi on 5 mRNA therapies program.

Today’s conference was a great opportunity to discuss this deal and to hear Sean’s vision on the future of the Biotech mRNA field.

Founded only 4 years ago, this German biotech is certainly going places then. Last year they opened a massive 10,000 square metre research centre with Ganymed, also located on the Johannes-Gutenberg campus, as well as recently signing a deal with Tech Giant Siemens for another new production plant.

Biontech_mrna_conference_berlin


Here’s the interview with Sean…

Let's Continue The Conversation

Feel free to send us comments about this article to comments@labiotech.eu and/or comment on that article on social media.

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.